ID

14451

Descripción

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia; ODM derived from: https://clinicaltrials.gov/show/NCT00220311

Link

https://clinicaltrials.gov/show/NCT00220311

Palabras clave

Versiones (1)
  1. 15/4/16 15/4/16 -
Subido en

15 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia, Lymphocytic, Chronic, B-Cell NCT00220311

Inglés

Eligibility Leukemia, Lymphocytic, Chronic, B-Cell NCT00220311

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically or cytologically confirmed cll
Descripción

CLL

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023434
patients with hemoglobin concentration and/or platelet count below the institution's lower limit of normal
Descripción

Hemoglobin and platelet count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0032181
patients who have not received cancer chemotherapy or radiotherapy
Descripción

No chemotherapy or radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332155
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with apparent infections (including viral infections)
Descripción

Infections

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
patients with serious complications (heart, liver, or kidney disease, etc.)
Descripción

Complications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009566
patients with a serious bleeding tendency (e.g., dic)
Descripción

Bleeding tendency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005779
patients with serious cns symptoms
Descripción

CNS symptoms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0422879
patients with fever >= 38°c (excluding tumor fever)
Descripción

Fever (excluding tumor fever)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0015967
UMLS CUI [2,1]
C0332196
UMLS CUI [2,2]
C0948348
patients with interstitial pneumonia or pulmonary fibrosis
Descripción

Interstitial pneumonia or pulmonary fibrosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206061
UMLS CUI [2]
C0034069
patients with active multiple cancers
Descripción

Multiple cancers

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0346429
patients receiving other investigational products within 6 months before registration in this study
Descripción

Experimental drug

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304229
patients with prior allergies to medications that are similar to the investigational product (purine nucleoside derivatives)
Descripción

Allergy to trial product

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3854006
women who are pregnant, of childbearing potential, or lactating
Descripción

Gynaecological status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C3831118
UMLS CUI [3]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Leukemia, Lymphocytic, Chronic, B-Cell NCT00220311

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
CLL
Item
patients with histologically or cytologically confirmed cll
boolean
C0023434 (UMLS CUI [1])
Hemoglobin and platelet count
Item
patients with hemoglobin concentration and/or platelet count below the institution's lower limit of normal
boolean
C0518015 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
No chemotherapy or radiotherapy
Item
patients who have not received cancer chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Infections
Item
patients with apparent infections (including viral infections)
boolean
C0009450 (UMLS CUI [1])
Complications
Item
patients with serious complications (heart, liver, or kidney disease, etc.)
boolean
C0009566 (UMLS CUI [1])
Bleeding tendency
Item
patients with a serious bleeding tendency (e.g., dic)
boolean
C0005779 (UMLS CUI [1])
CNS symptoms
Item
patients with serious cns symptoms
boolean
C0422879 (UMLS CUI [1])
Fever (excluding tumor fever)
Item
patients with fever >= 38°c (excluding tumor fever)
boolean
C0015967 (UMLS CUI [1])
C0332196 (UMLS CUI [2,1])
C0948348 (UMLS CUI [2,2])
Interstitial pneumonia or pulmonary fibrosis
Item
patients with interstitial pneumonia or pulmonary fibrosis
boolean
C0206061 (UMLS CUI [1])
C0034069 (UMLS CUI [2])
Multiple cancers
Item
patients with active multiple cancers
boolean
C0346429 (UMLS CUI [1])
Experimental drug
Item
patients receiving other investigational products within 6 months before registration in this study
boolean
C0304229 (UMLS CUI [1])
Allergy to trial product
Item
patients with prior allergies to medications that are similar to the investigational product (purine nucleoside derivatives)
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
Gynaecological status
Item
women who are pregnant, of childbearing potential, or lactating
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial